Trifecta Research Study
Axial Therapeutic Research · PTSD - Post Traumatic Stress Disorder · Cognitive Dysfunction
Not applicable
Active, not recruiting
52
2026-07
A source-linked view of every Ipamorelin study in the current snapshot—status, phase, enrollment, results, publications, locations and changes over time.
Largest indexed study
320 participants · NCT01280344 →Developer / research origin
Novo Nordisk
Evidence summary
Ipamorelin appears in 3 indexed studies: 0 recruiting, 2 completed and 0 with registry results posted. The highest registered development stage in this snapshot is Phase 2. These counts measure registry activity; they do not establish that Ipamorelin is safe or effective.
Review the design, endpoints, population, protocol changes, statistical analysis and publications before drawing conclusions.
Current studies
Completed studies
Stopped studies
Axial Therapeutic Research · PTSD - Post Traumatic Stress Disorder · Cognitive Dysfunction
Not applicable
Active, not recruiting
52
2026-07
Helsinn Therapeutics (U.S.), Inc · Ileus
Phase 2
Completed
117
2017-04
Helsinn Therapeutics (U.S.), Inc · Gastrointestinal Dysmotility
Phase 2
Completed
320
2017-04
Full study index
Add status, phase, condition, country, result and publication filters inside this molecule’s indexed study set.
3 matching studies
Last registry update first
Latest publications
Related pages
Commercial research listings, where present, are kept separate from clinical evidence and are not treatment recommendations.